Sedgwick County Health News: Wegovy Now a Game-Changer in Heart Health. Doctor Explains

Cover Image: Sedgwick County Health News:  Wegovy Now a Game-Changer in Heart Health. Doctor Explains

A new study has shown that semaglutide can significantly reduce the risk of major adverse cardiovascular events in patients even for those who don't have diabetes.

The Big Picture: Dr. Adriana Davis, Family Medicine, "These findings from the study are simply spectacular for your heart health!"

Doctor's Expert Insights about the Medicines Like Wegovy for Heart Health in Sedgwick County, Colorado

Know this: "Medicines like Wegovy, are being shown to be much more than 'a weight-loss drug.' The implications of these findings suggest that doctors could prescribe Wegovy to not only assist in weight management but also to offer a protective benefit against heart attacks, strokes, and heart-related deaths. Healthcare providers will have to consider incorporating this medication into the treatment plans for their patients. Keep in mind that lifestyle changes and pharmacological interventions can be used to optimize heart health." Dr. Puja Uppal, Family Medicine.

Next Steps: Make sure you know your A1c, cholesterol, and blood pressure values. These are key in the management of both diabetes and your heart health.

Health News Today: Weight loss Drugs like Ozempic and Wegovy have Heart Health Benefits as Well.

Key Findings for you in for Sedgwick County:

Background

Semaglutide has been demonstrated to lower the risk of cardiovascular events, such as heart attacks and strokes, in patients who have been diagnosed with diabetes.

The purpose of the study was to determine if semaglutide, a medication known to reduce cardiovascular risk in patients with diabetes, could also lower the risk of cardiovascular events in individuals who are overweight or obese but do not have diabetes.

Methods

Multicenter, double-blind, randomized, placebo-controlled, event-driven superiority trial.

Enrolled patients: 45 years or older with pre-existing cardiovascular disease. Their BMI was greater than or equal to 27 and they had no history of diabetes.

Results

Total patients enrolled: 17,604 (8,803 were on semaglutide and 8,801 received a placebo..

Mean exposure duration: 34.2 months.

Mean follow-up duration: 39.8 months.

The primary goal was to observe cardiovascular events (such as heart attacks, strokes, or cardiovascular-related deaths). In the semaglutide group, 6.5% of participants experienced such an event. In the placebo group, 8.0% of the people experienced a cardiovascular event.

Conclusions

In patients with pre-existing cardiovascular disease, overweight or obesity, but without diabetes, weekly subcutaneous semaglutide (2.4 mg) was superior to placebo in reducing the incidence of cardiac issues. In other words, Semaglutide is shown to be effective in managing heart disease for people without diabetes!

Medical News Today: Key Takeaway for You in Sedgwick County

For people who have heart disease but not diabetes, medicines like Wegovy's are showing a dual role in promoting weight loss and protecting against serious heart conditions. This presents a significant advancement in the treatment of heart disease patients without diabetes.

"It moves from a kind of therapy that reduces body weight to a therapy that reduces cardiovascular events..." Dr. A. Michael Lincoff, Cardiologist.

What They're Saying: "Medications in the GLP-1 receptor agonist class have been shown in animals with or without diabetes to reduce inflammation, improve endothelial and left ventricular function, promote plaque stability, and decrease platelet aggregation.16 In this trial, semaglutide was associated with changes in multiple biomarkers of cardiovascular risk, including blood pressure, waist circumference, glycemic control, nephropathy, and levels of lipids and C-reactive protein." (Study Source)

Health Standard Newswire: The implications of Wegovy's study extend far into the future of healthcare by potentially transforming the management of obesity and heart disease.

Medical News and Statistics for Sedgwick County, Colorado

The following health facts impact your physical health directly!

Did you know there were 8081 deaths from heart disease in Colorado in 2021?

28% of you in Sedgwick County are obese.

16.9% of you in Sedgwick County don't have health insurance.

8.8% of you in Sedgwick County have been diagnosed with diabetes.

All of these variables above play an important role in the outcomes of your overall health.

The Health Standard Newswire.